angiotensin ii, des-phe(8)- has been researched along with quinacrine in 1 studies
| Studies (angiotensin ii, des-phe(8)-) | Trials (angiotensin ii, des-phe(8)-) | Recent Studies (post-2010) (angiotensin ii, des-phe(8)-) | Studies (quinacrine) | Trials (quinacrine) | Recent Studies (post-2010) (quinacrine) |
|---|---|---|---|---|---|
| 1,533 | 21 | 995 | 4,051 | 65 | 289 |
| Protein | Taxonomy | angiotensin ii, des-phe(8)- (IC50) | quinacrine (IC50) |
|---|---|---|---|
| cystic fibrosis transmembrane conductance regulator | Homo sapiens (human) | 19.88 | |
| Major prion protein | Mus musculus (house mouse) | 0.0951 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.896 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.964 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 1.983 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 4.5 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 4.5 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 4.5 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 4.5 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 3.736 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 2.28 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 4.5 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 1.489 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 1.825 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 3.857 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 1.255 | |
| Acetylcholinesterase | Homo sapiens (human) | 2.667 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.896 | |
| Histamine H2 receptor | Homo sapiens (human) | 3.535 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 2.065 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 2.663 | |
| D(3) dopamine receptor | Homo sapiens (human) | 1.318 | |
| Aldehyde oxidase 1 | Oryctolagus cuniculus (rabbit) | 10 | |
| Cholinesterase | Equus caballus (horse) | 4.5 | |
| Aldehyde oxidase | Homo sapiens (human) | 3.3 | |
| Cyclic GMP-AMP synthase | Homo sapiens (human) | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caruso-Neves, C; Fernandes, MS; Leão-Ferreira, LR; Lopes, AG; Quintana-Gomes, E; Santos, DP; Soares, AC | 1 |
1 other study(ies) available for angiotensin ii, des-phe(8)- and quinacrine
| Article | Year |
|---|---|
PLA2/PGE2 are involved in the inhibitory effect of bradykinin on the angiotensin-(1-7)-stimulated Na(+)-ATPase activity of the proximal tubule.
Topics: Angiotensin I; Animals; Bradykinin; Bradykinin B2 Receptor Antagonists; Cell Membrane; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Dose-Response Relationship, Drug; Indomethacin; Kidney Tubules, Proximal; Peptide Fragments; Phospholipases A; Phospholipases A2; Quinacrine; Receptor, Bradykinin B2; Sodium-Potassium-Exchanging ATPase; Swine | 2004 |